Reversal of acute allograft rejection with monoclonal antibody

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


OKT3 is a very effective drug when used for reversal of acute allograft rejection. The excellent long-term graft survival of the patients in this study indicates that it is also an effective adjunctive therapy for promoting long-term graft survival. The problems encountered with early rerejection in high responder patients will promote an alteration of currently used protocols to accommodate these patients.

Original languageEnglish (US)
Pages (from-to)39-41
Number of pages3
JournalTransplantation proceedings
Issue number1 I
StatePublished - 1985

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Reversal of acute allograft rejection with monoclonal antibody'. Together they form a unique fingerprint.

Cite this